Teleflex (TFX) Total Non-Current Liabilities (2009 - 2026)
Teleflex's (TFX) quarterly Total Non-Current Liabilities came in at $3.7 billion in Q1 2026, up 19.07% YoY from $3.1 billion in Q1 2025, and down 3.14% on a QoQ basis from $3.8 billion in Q4 2025.
Teleflex (TFX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Teleflex (TFX) has 18 years of Total Non-Current Liabilities data on file, last reported at $3.7 billion in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 19.07% year-over-year to $3.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 billion (up 19.07% YoY) and the FY2025 annual result came in at $3.8 billion, up 33.77% from the prior year.
- Total Non-Current Liabilities declined to $3.7 billion in Q1 2026, from $3.8 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $3.9 billion in Q3 2025 to a low of $2.6 billion in Q3 2023.
- A 5-year average of $3.0 billion and a median of $2.9 billion in 2022 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities decreased 20.04% — and 2025, when it surged 36.67%.
- Tracing TFX's Total Non-Current Liabilities over 5 years: stood at $2.9 billion in 2022, then rose by 0.99% to $2.9 billion in 2023, then slipped by 3.79% to $2.8 billion in 2024, then jumped by 33.77% to $3.8 billion in 2025, then declined by 3.14% to $3.7 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $3.7 billion (Q1 2026), $3.8 billion (Q4 2025), and $3.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Teleflex | 6.03 Bn | 5.73 Bn | 331.71 Mn | 3.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.82 Bn |
| Mar 31, 2026 | 3.65 Bn |
| Dec 31, 2025 | 3.77 Bn |
| Sep 28, 2025 | 3.90 Bn |
| Jun 29, 2025 | 3.01 Bn |
| Mar 30, 2025 | 3.07 Bn |
| Dec 31, 2024 | 2.82 Bn |
| Sep 29, 2024 | 2.86 Bn |
| Jun 30, 2024 | 2.76 Bn |
| Mar 31, 2024 | 2.97 Bn |
| Dec 31, 2023 | 2.93 Bn |
| Oct 1, 2023 | 3.07 Bn |
| Jul 2, 2023 | 2.56 Bn |
| Apr 2, 2023 | 2.67 Bn |
| Dec 31, 2022 | 2.90 Bn |
| Sep 25, 2022 | 2.74 Bn |
| Jun 26, 2022 | 2.87 Bn |
| Mar 27, 2022 | 2.93 Bn |
| Dec 31, 2021 | 2.96 Bn |
| Sep 26, 2021 | 3.37 Bn |